The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence

Overview

Journal Nutrients

Date 2019 May 31

PMID 31141890

Citations 39

Authors

Martin Schon

Aya Mousa

Michael Berk

Wern L Chia

Jozef Ukropec

Arshad Majid

Barbara Ukropcova

Barbora de Courten

Affiliations

Soon will be listed here.

Abstract

Neurological, neurodegenerative, and psychiatric disorders represent a serious burden because of their increasing prevalence, risk of disability, and the lack of effective causal/disease-modifying treatments. There is a growing body of evidence indicating potentially favourable effects of carnosine, which is an over-the-counter food supplement, in peripheral tissues. Although most studies to date have focused on the role of carnosine in metabolic and cardiovascular disorders, the physiological presence of this di-peptide and its analogues in the brain together with their ability to cross the blood-brain barrier as well as evidence from in vitro, animal, and human studies suggest carnosine as a promising therapeutic target in brain disorders. In this review, we aim to provide a comprehensive overview of the role of carnosine in neurological, neurodevelopmental, neurodegenerative, and psychiatric disorders, summarizing current evidence from cell, animal, and human cross-sectional, longitudinal studies, and randomized controlled trials.

Citing Articles

Effects of β-Alanine Supplementation on Subjects Performing High-Intensity Functional Training.

Cimadevilla-Fernandez-Pola E, Martinez-Roldan C, Mate-Munoz J, Guodemar-Perez J, Sanchez-Calabuig M, Garcia-Fernandez P Nutrients. 2024; 16(14).

PMID: 39064783 PMC: 11280034. DOI: 10.3390/nu16142340.

State of the Art in the Development of Human Serum Carnosinase Inhibitors.

Regazzoni L Molecules. 2024; 29(11).

PMID: 38893364 PMC: 11173852. DOI: 10.3390/molecules29112488.

Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis.

Wurtz L, Knyazhanskaya E, Sohaei D, Prassas I, Pittock S, Willrich M Clin Proteomics. 2024; 21(1):42.

PMID: 38880880 PMC: 11181608. DOI: 10.1186/s12014-024-09494-5.

Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial.

Saadati S, Cameron J, Menon K, Hodge A, Lu Z, de Courten M Nutrients. 2023; 15(22).

PMID: 38004228 PMC: 10674211. DOI: 10.3390/nu15224835.

Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability.

Pires P, Paiva-Santos A, Veiga F Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895895 PMC: 10610493. DOI: 10.3390/ph16101424.

References

Boldyrev A, Johnson P, Wei Y, Tan Y, Carpenter D . Carnosine and taurine protect rat cerebellar granular cells from free radical damage. Neurosci Lett. 1999; 263(2-3):169-72. DOI: 10.1016/s0304-3940(99)00150-0. View

Gold R, Hartung H, Toyka K . Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today. 2000; 6(2):88-91. DOI: 10.1016/s1357-4310(99)01639-1. View

Kwan P, Brodie M . Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5):314-9. DOI: 10.1056/NEJM200002033420503. View

Horning M, Blakemore L, Trombley P . Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine. Brain Res. 2000; 852(1):56-61. DOI: 10.1016/s0006-8993(99)02215-5. View

Berney T . Autism--an evolving concept. Br J Psychiatry. 2000; 176:20-5. DOI: 10.1192/bjp.176.1.20. View

Keller K, Chu Y, Grider A, Coffield J . Supplementation with L-histidine during dietary zinc repletion improves short-term memory in zinc-restricted young adult male rats. J Nutr. 2000; 130(6):1633-40. DOI: 10.1093/jn/130.6.1633. View

Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D . Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem. 2000; 267(13):4171-8. DOI: 10.1046/j.1432-1327.2000.01452.x. View

De Marchis S, Modena C, Peretto P, Migheli A, Margolis F, Fasolo A . Carnosine-related dipeptides in neurons and glia. Biochemistry (Mosc). 2000; 65(7):824-33. View

Lewis D, Lieberman J . Catching up on schizophrenia: natural history and neurobiology. Neuron. 2001; 28(2):325-34. DOI: 10.1016/s0896-6273(00)00111-2. View

10.

Lee J, Cole T, Palmiter R, Suh S, Koh J . Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(11):7705-10. PMC: 124328. DOI: 10.1073/pnas.092034699. View

11.

Chez M, Buchanan C, Aimonovitch M, Becker M, Schaefer K, Black C . Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol. 2003; 17(11):833-7. DOI: 10.1177/08830738020170111501. View

12.

Aldred S, Moore K, Fitzgerald M, Waring R . Plasma amino acid levels in children with autism and their families. J Autism Dev Disord. 2003; 33(1):93-7. DOI: 10.1023/a:1022238706604. View

13.

Carini M, Aldini G, Beretta G, Arlandini E, Maffei Facino R . Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2003; 38(9):996-1006. DOI: 10.1002/jms.517. View

14.

Kaminski R, Zolkowska D, Kozicka M, Kleinrok Z, Czuczwar S . L-histidine is a beneficial adjuvant for antiepileptic drugs against maximal electroshock-induced seizures in mice. Amino Acids. 2004; 26(1):85-9. DOI: 10.1007/s00726-003-0005-0. View

15.

Tomonaga S, Tachibana T, Takagi T, Saito E, Zhang R, Denbow D . Effect of central administration of carnosine and its constituents on behaviors in chicks. Brain Res Bull. 2004; 63(1):75-82. DOI: 10.1016/j.brainresbull.2004.01.002. View

16.

Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J . European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry. 2004; 13 Suppl 1:I7-30. DOI: 10.1007/s00787-004-1002-x. View

17.

Banaschewski T, Roessner V, Dittmann R, Santosh P, Rothenberger A . Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004; 13 Suppl 1:I102-16. DOI: 10.1007/s00787-004-1010-x. View

18.

Shao L, Li Q, Tan Z . L-carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts. Biochem Biophys Res Commun. 2004; 324(2):931-6. DOI: 10.1016/j.bbrc.2004.09.136. View

19.

Ishiwari K, Mingote S, Correa M, Trevitt J, Carlson B, Salamone J . The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis. J Neurosci Methods. 2004; 140(1-2):39-46. DOI: 10.1016/j.jneumeth.2004.03.030. View

20.

Adachi N, Liu K, Arai T . Prevention of brain infarction by postischemic administration of histidine in rats. Brain Res. 2005; 1039(1-2):220-3. DOI: 10.1016/j.brainres.2005.01.061. View